US Stock MarketDetailed Quotes

CRNX Crinetics

Watchlist

33.750
+0.470+1.41%

Close Mar 10 16:00 ET

33.070
-0.680-2.01%

Pre 04:05 ET

3.14BMarket Cap-9.15P/E (TTM)

Crinetics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Crinetics Q4 2024 Earnings Date

Currency：USDFeb 27, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
EPS	-0.90	-0.88	+0.02
Beat Est.	+0.23%	+2.22%	+1.98%
Net Income	--	-80.60M	--
		-34.11%

Analyst Rating

Strong Buy

Mar 10, 2025

Crinetics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 382.700K	--
--	2025/Q1	-- / 110.000K	--
Feb 27, 2025	2024/Q4	0.000 / 727.270K	--
Nov 12, 2024	2024/Q3	0.000 / 239.900K	--
Aug 8, 2024	2024/Q2	399.000K / 467.270K	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 382.700K--

--2025/Q1-- / 110.000K--

Feb 27, 20252024/Q40.000 / 727.270K--

Nov 12, 20242024/Q30.000 / 239.900K--

Aug 8, 20242024/Q2399.000K / 467.270K--

Unlock Free Earnings Estimates

Open Account

Crinetics Earnings Reports

Crinetics | 10-K: FY2024 Annual Report

Feb 27 16:13 ET

Crinetics | 8-K: Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 27 16:11 ET

Crinetics | 10-Q: Q3 2024 Earnings Report

Nov 12, 2024 16:21 ET

Crinetics | 8-K: Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 12, 2024 16:14 ET